Bon Natural Life Limited
BON · NASDAQ
3/31/2025 | 9/30/2024 | 3/31/2024 | 9/30/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | -0.02 | 31.68 | 0.89 |
| FCF Yield | -606.55% | -6.73% | -1.41% | 1.06% |
| EV / EBITDA | 0.48 | 72.22 | 181.25 | 27.80 |
| Quality | ||||
| ROIC | 0.20% | 2.11% | -0.16% | 6.08% |
| Gross Margin | 24.00% | 30.32% | 29.15% | 26.82% |
| Cash Conversion Ratio | -25.38 | -13.64 | 179.10 | 0.62 |
| Growth | ||||
| Revenue 3-Year CAGR | 7.72% | 15.52% | 24.56% | 29.80% |
| Free Cash Flow Growth | 26.51% | -210.10% | -284.40% | 146.54% |
| Safety | ||||
| Net Debt / EBITDA | -0.11 | 5.54 | 7.71 | 1.13 |
| Interest Coverage | 1.73 | 11.22 | 0.59 | 24.58 |
| Efficiency | ||||
| Inventory Turnover | 0.45 | 6.05 | 0.43 | 11.39 |
| Cash Conversion Cycle | 341.09 | 60.29 | 265.84 | 23.60 |